Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Near-Infrared Stimulation in Psychiatry Disorders: A Systematic Review of Efficacy and Biological Mechanisms

Preliminary results support the potential of NIR stimulation as a novel and innovative treatment for psychiatry. Further studies are needed to estimate the proper protocols of parameters singly for any disease.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors conducted a systematic review of pre-clinical and clinical studies on photobiomodulation, a near-infrared light therapy, for psychiatric disorders. They report that it is presented as effective and comparable to psychopharmacological treatment, with a proposed mechanism involving cytochrome C oxidase, and that preliminary results are promising. Clinical studies varied widely and most lacked a suitable control group, so further research is needed.

Studies included
23
Who or what was studied
Individuals with psychiatric disorders including major depressive disorder, generalized anxiety disorder, dementia, Parkinson's disease, traumatic brain injury, schizophrenia, and sexual dysfunctions, plus pre-clinical studies
Limits stated in the abstract
Clinical studies varied in population and treatment parameters, and most did not include a suitable control group.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

Photobiomodulation (PBM), also referred to as low-level light therapy (LLLT), is an emerging non-pharmacological approach. This treatment is considered low-risk, cost-effective, and non-invasive, utilizing near-infrared light (NIR). The purpose of this paper is to explore the underlying mechanism of action and conduct a systematic review of pre-clinical and clinical research on the use of PBM for psychiatric disorders.

Methods

A search on the PubMed, Cochrane Library, and EMBASE databases was performed on 18 and 26 January 2024. Publications focused on PBM treatment in psychiatric disorders such as major depressive disorder, general anxiety disorder, dementia, Parkinson's disease, traumatic brain injury, schizophrenia, and sexual disfunctions were included (n = 23).

Results

Near-infrared stimulation is presented as an effective method, comparable to psychopharmacological treatment. The primary suggested mechanism for PBM is the stimulation of mitochondrial metabolism following the absorption of NIR energy by cytochrome C oxidase. Because of the method of implementation, which omits the liver metabolism of cytochrome P450, PMB is recognized as safe as it does not interact with other drugs. LIMITATIONS: Clinical studies vary in terms of population and treatment parameters, and most do not include a suitable control group.

Conclusions

Preliminary results support the potential of NIR stimulation as a novel and innovative treatment for psychiatry. Further studies are needed to estimate the proper protocols of parameters singly for any disease.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Near-infrared, Photobiomodulation, Systematic review, Low-level laser therapy, Traumatic brain injury, Cytochrome c oxidase, Control group, Brain injury. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies